Ultragenyx Pharmaceutical | RARE - القيمة السوقية





القيمة السوقية تغيير تاريخ
Acadia Pharmaceuticals USD 4.33B 537M 2026-06
Alnylam Pharmaceuticals USD 40.19B 3.96B 2026-06
BioCryst Pharmaceuticals USD 2.54B 880M 2026-06
BioMarin Pharmaceutical USD 11.06B 196M 2026-06
Immunic USD 64M 23M 2025-12
Insmed USD 23.11B 12.19B 2026-06
Ionis Pharmaceuticals USD 13.1B 642M 2026-06
Karyopharm Therapeutics USD 126M 9M 2026-03
Kyowa Hakko Kirin JPY 1.36T 4.73B 2026-06
MacroGenics USD 184M 82M 2026-03
Neurocrine Biosciences USD 16.95B 3.7B 2026-06
Regeneron Pharmaceuticals USD 65.37B 16.31B 2026-06
Sarepta Therapeutics USD 1.9B 388M 2026-06
Ultragenyx Pharmaceutical USD 3.29B 1.23B 2026-06
Vertex Pharmaceuticals USD 126.07B 12.49B 2026-06